Editor’s Note
**Editor’s Note:** Huons Group is ramping up its expansion into China with the launch of its botulinum toxin product, Hutox, following a recent symposium in Hangzhou.
Huons Group is accelerating its push into the Chinese market with its botulinum toxin product ‘Hutox’.
Huons Group subsidiaries Humedix and Huons Biopharma announced on the 20th that they held the ‘Hutox Launch Symposium’ on the 16th at the JW Marriott Hotel in Hangzhou, Zhejiang Province, China. The event was hosted by ‘Aimeike Technology’, Huons Biopharma’s exclusive distribution partner in China.
At the symposium, the official launch of Hutox was announced, along with academic exchanges targeting local medical professionals and industry stakeholders.
Hutox, used for improving glabellar and periorbital wrinkles, received product approval from China’s National Medical Products Administration (NMPA) in January.
Humedix supported the invitation of speakers and communication for this academic event based on its domestic medical professional network.